Fludarabine, Rituximab, and Lenalidomide in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL): A Phase I/II Trial of the Sarah Cannon Research Institute

Autor:	Flinn, Ian W., Cooper, R. Seth, Thompson, Dana S. *, Waselenko, Jamie K. *, Reeves, James, Jr. *, Wise, Rudolph L., Hainsworth, John D., Berdeja, Jesus G.
Zdroj:	In Blood 16 November 2012 120(21):715-715
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu